共 50 条
- [24] Bevacizumab increases the risk of gastrointestinal perforation in cancer patients: a meta-analysis with a focus on different subgroups [J]. European Journal of Clinical Pharmacology, 2014, 70 : 893 - 906
- [26] Meta-analysis [J]. INTERNATIONAL REVIEW OF SPORT AND EXERCISE PSYCHOLOGY, 2022, 15 (01) : 120 - 151